Ownership Summary
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) has 66 institutional investors with active 13F positions as of December 2025.
- They owned 19.8% of outstanding stock in December 2025, down from 23.0% the prior quarter.
- Their total shares held in RNAC increased 3.16% quarter over quarter, and separately, investors owning Cartesian Therapeutics decreased 4.35% from a year ago.
- Of these 66 funds, 37 grew their exposure to Cartesian Therapeutics, 16 cut back, and 13 maintained positions.
- The aggregate institutional position in Cartesian Therapeutics amounted to 5.15Mn shares as of December 2025, up by 157.65K shares quarter on quarter, and down 1.56Mn shares year over year.
- As of December 31, 2025, IRONWOOD INVESTMENT MANAGEMENT LLC held the largest stake in Cartesian Therapeutics with 170.09K shares, accounting for 0.65% of total shares outstanding.
- Per Business Quant, the top 2 investors in RNAC for the quarter ending December 2025 include IRONWOOD INVESTMENT MANAGEMENT LLC (170.09K), Sterling Capital Management LLC (8.27K).